Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

Daiichi, AstraZeneca enter clinical trial cooperation with Summit

2nd Oct 2026 10:14

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday said they entered into a clinical trial collaboration with the biopharmaceutical oncology company Summit Therapeutics Inc to evaluate the use of Datroway in combination with ivonescimab in treating multiple tumour types. Read More

WINNERS & LOSERS: Vesuvius soars on bid; Zigup lifts outlook

29th Sep 2026 10:21

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

Hutchmed says AstraZeneca files US application for Orpathys

29th Sep 2026 10:20

(Alliance News) - Hutchmed China Ltd on Tuesday said AstraZeneca PLC submitted a new drug application to the US Food & Drug Administration for Orpathys, or savolitinib, in combination with Tagrisso for patients with non-small cell lung cancer. Read More

LONDON MARKET OPEN: Stocks rise as pharma and miners advance

29th Sep 2026 09:09

(Alliance News) - Stock prices in London opened higher on Tuesday, as pharmaceutical and mining stocks advanced, while oil prices eased amid signs of progress towards renewed talks between the US and Iran. Read More

LONDON BRIEFING: Astra files US cancer NDA; Close Bros loss narrows

29th Sep 2026 08:00

(Alliance News) - AstraZeneca submits a US regulatory application for a lung cancer treatment developed with Hutchmed. Close Brothers reports a narrowed annual loss but withholds its dividend amid motor finance uncertainty, while Zigup raises its annual profit expectations after a strong start to the year. Read More

LONDON MARKET MIDDAY: Stocks rise as Hormuz hopes push oil lower

25th Sep 2026 12:10

(Alliance News) - Stock prices in London were higher at midday on Friday as hopes for progress towards reopening the Strait of Hormuz pushed oil prices lower, although Brent stayed above USD100, while global bond yields remained elevated. Read More

AstraZeneca hails US priority review for Imfinzi for bladder cancer

25th Sep 2026 10:29

(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration granted priority review for its human monoclonal antibody Imfinzi for a form of bladder cancer. Read More

LONDON BRIEFING: Harworth backs Peel bid; Iran sets Hormuz plan

25th Sep 2026 07:59

(Alliance News) - United Utilities leaves its financial guidance for 2027 unchanged, while Harworth backs an increased takeover offer from Peel Holdings. Meanwhile, Iran proposes a seven-day plan to reopen the Strait of Hormuz and restart talks with the US. Read More

AstraZeneca celebrates EU approval of Trixeo for treating asthma

23rd Sep 2026 08:56

(Alliance News) - AstraZeneca PLC on Wednesday said the EU approved Trixeo Aerosphere for the maintenance treatment of asthma. Read More

LONDON BRIEFING: Airtel eyes major IPO; JD Sports holds guidance

23rd Sep 2026 07:59

(Alliance News) - Airtel Africa's mobile money business plans what could be one of London's biggest IPOs in recent years. JD Sports reports a sharp fall in adjusted first-half profit but maintains its annual guidance, while Diageo appoints WPP's Joanne Wilson as its new chief financial officer. Read More

LONDON MARKET CLOSE: FTSE 100 slides as bond yields resume upward path

18th Sep 2026 17:02

(Alliance News) - The FTSE 100 fell heavily on Friday as bond yields pushed higher amid fears that higher inflation will keep interest rates elevated. Read More

AstraZeneca drug Klygefa gains positive opinion from EU's CHMP

18th Sep 2026 15:27

(Alliance News) - AstraZeneca PLC on Friday announced that Klygefa has been recommended for approval in the EU, as a treatment for generalised myasthenia gravis. Read More

AstraZeneca, Daiichi celebrate another recommended approval of Enhertu

18th Sep 2026 14:04

(Alliance News) - AstraZeneca PLC and its partner Daiichi Sankyo Co Ltd on Friday announced that their cancer drug Enhertu has been recommended to be approved in the EU for a form of breast cancer. Read More

LONDON MARKET MIDDAY: FTSE 100 falls as Airtel Africa tumbles

18th Sep 2026 12:28

(Alliance News) - Stock prices in London were mixed at midday on Friday, with the FTSE 100 weighed down by steep losses for Airtel Africa. Read More

IN BRIEF: AstraZeneca chief executive buys GBP7 million in shares

18th Sep 2026 11:34

AstraZeneca PLC - Cambridge, England-based pharmaceutical company - Chief Executive Officer Pascal Soriot buys 60,000 shares at GBP121.02, worth GBP7.3 million, on Monday in London. Read More

WINNERS & LOSERS: Airtel Africa falls; Softcat funds US deal

18th Sep 2026 10:17

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

LONDON MARKET OPEN: Shares fall despite stronger UK retail sales

18th Sep 2026 09:29

(Alliance News) - Stock prices in London opened lower on Friday, despite stronger-than-expected UK retail sales, as weakness in Airtel Africa weighed on the FTSE 100. Read More

LONDON BROKER RATINGS: Berenberg and Deutsche say buy Bytes Technology

18th Sep 2026 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

AstraZeneca hails US priority review designation for efzimfotase alfa

18th Sep 2026 08:42

(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration granted a 'priority review' designation for efzimfotase alfa, an investigational enzyme replacement therapy. Read More

LONDON BRIEFING: UK retail sales rebound; Softcat completes fundraise

18th Sep 2026 07:59

(Alliance News) - UK retail sales rebound in August and beat market expectations. AstraZeneca's efzimfotase alfa receives 'Priority Review' in the US for the treatment of hypophosphatasia, while Softcat raises GBP354 million to help fund its USD1.05 billion acquisition of GDT. Read More

FTSE 100 Latest
Value10,506.58
Change-44.59